[HTML][HTML] Transcription factor Nrf2 as a potential therapeutic target for COVID-19
Y Wang, J Ma, Y Jiang - Cell Stress and Chaperones, 2023 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) is caused by a novel severe acute
respiratory syndrome (SARS)–like coronavirus (SARS-CoV-2). Critically ill patients with …
respiratory syndrome (SARS)–like coronavirus (SARS-CoV-2). Critically ill patients with …
Transcription factor Nrf2 as a potential therapeutic target for COVID-19
Y Wang, J Ma, Y Jiang - Cell stress & chaperones, 2023 - pubmed.ncbi.nlm.nih.gov
The coronavirus disease 2019 (COVID-19) is caused by a novel severe acute respiratory
syndrome (SARS)-like coronavirus (SARS-CoV-2). Critically ill patients with SARS-COV-2 …
syndrome (SARS)-like coronavirus (SARS-CoV-2). Critically ill patients with SARS-COV-2 …
Transcription factor Nrf2 as a potential therapeutic target for COVID-19.
Y Wang, J Ma, Y Jiang - Cell Stress & Chaperones, 2023 - search.ebscohost.com
Abstract The coronavirus disease 2019 (COVID-19) is caused by a novel severe acute
respiratory syndrome (SARS)–like coronavirus (SARS-CoV-2). Critically ill patients with …
respiratory syndrome (SARS)–like coronavirus (SARS-CoV-2). Critically ill patients with …
[HTML][HTML] Transcription factor Nrf2 as a potential therapeutic target for COVID-19
Y Wang, J Ma, Y Jiang - Cell Stress and Chaperones, 2023 - Springer
Abstract The coronavirus disease 2019 (COVID-19) is caused by a novel severe acute
respiratory syndrome (SARS)–like coronavirus (SARS-CoV-2). Critically ill patients with …
respiratory syndrome (SARS)–like coronavirus (SARS-CoV-2). Critically ill patients with …
Transcription factor Nrf2 as a potential therapeutic target for COVID-19.
Y Wang, J Ma, Y Jiang - Cell Stress & Chaperones, 2022 - europepmc.org
Abstract The coronavirus disease 2019 (COVID-19) is caused by a novel severe acute
respiratory syndrome (SARS)–like coronavirus (SARS-CoV-2). Critically ill patients with …
respiratory syndrome (SARS)–like coronavirus (SARS-CoV-2). Critically ill patients with …
Transcription factor Nrf2 as a potential therapeutic target for COVID-19
Y Wang, J Ma, Y Jiang - Cell Stress & Chaperones, 2023 - JSTOR
Abstract The coronavirus disease 2019 (COVID-19) is caused by a novel severe acute
respiratory syndrome (SARS)–like coronavirus (SARS-CoV-2). Critically ill patients with …
respiratory syndrome (SARS)–like coronavirus (SARS-CoV-2). Critically ill patients with …
[PDF][PDF] Transcription factor Nrf2 as a potential therapeutic target for COVID‑19
Y Wang, J Ma, Y Jiang - Cell Stress and Chaperones, 2023 - redoxscience.com
Abstract The coronavirus disease 2019 (COVID-19) is caused by a novel severe acute
respiratory syndrome (SARS)–like coronavirus (SARS-CoV-2). Critically ill patients with …
respiratory syndrome (SARS)–like coronavirus (SARS-CoV-2). Critically ill patients with …
[HTML][HTML] Transcription factor Nrf2 as a potential therapeutic target for COVID-19
Y Wang, J Ma, Y Jiang - Cell Stress & Chaperones, 2023 - ncbi.nlm.nih.gov
Abstract The coronavirus disease 2019 (COVID-19) is caused by a novel severe acute
respiratory syndrome (SARS)–like coronavirus (SARS-CoV-2). Critically ill patients with …
respiratory syndrome (SARS)–like coronavirus (SARS-CoV-2). Critically ill patients with …
Transcription factor Nrf2 as a potential therapeutic target for COVID-19.
Y Wang, J Ma, Y Jiang - Cell Stress & Chaperones, 2022 - europepmc.org
The coronavirus disease 2019 (COVID-19) is caused by a novel severe acute respiratory
syndrome (SARS)-like coronavirus (SARS-CoV-2). Critically ill patients with SARS-COV-2 …
syndrome (SARS)-like coronavirus (SARS-CoV-2). Critically ill patients with SARS-COV-2 …